Femasys IncNASDAQ:FEMY
- LAST PRICE1.3300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 1.3300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FEMY |
|---|---|---|
| 09:32 ET | 753 | 1.34 |
| 09:36 ET | 5000 | 1.3699 |
| 09:38 ET | 1764 | 1.355 |
| 09:41 ET | 250 | 1.364 |
| 09:43 ET | 150 | 1.3432 |
| 09:45 ET | 200 | 1.3699 |
| 09:48 ET | 339 | 1.35 |
| 09:52 ET | 290 | 1.37 |
| 09:54 ET | 250 | 1.3692 |
| 09:56 ET | 4100 | 1.3657 |
| 09:57 ET | 115 | 1.3678 |
| 09:59 ET | 2854 | 1.37 |
| 10:08 ET | 700 | 1.37 |
| 10:14 ET | 831 | 1.39 |
| 10:15 ET | 10720 | 1.391 |
| 10:17 ET | 1901 | 1.4003 |
| 10:24 ET | 8800 | 1.4099 |
| 10:26 ET | 610 | 1.4 |
| 10:28 ET | 3110 | 1.3997 |
| 10:30 ET | 800 | 1.3998 |
| 10:32 ET | 218 | 1.4 |
| 10:33 ET | 2000 | 1.3999 |
| 10:35 ET | 2606 | 1.37 |
| 10:37 ET | 200 | 1.37 |
| 10:39 ET | 100 | 1.3801 |
| 10:46 ET | 1200 | 1.36 |
| 10:48 ET | 200 | 1.36 |
| 10:50 ET | 200 | 1.36 |
| 10:55 ET | 600 | 1.36 |
| 11:06 ET | 830 | 1.3682 |
| 11:08 ET | 859 | 1.3687 |
| 11:13 ET | 400 | 1.36 |
| 11:26 ET | 302 | 1.36 |
| 11:29 ET | 100 | 1.365 |
| 11:31 ET | 6071 | 1.365 |
| 11:33 ET | 500 | 1.3664 |
| 11:36 ET | 100 | 1.36 |
| 11:40 ET | 100 | 1.365 |
| 11:49 ET | 581 | 1.36 |
| 12:00 ET | 572 | 1.3688 |
| 12:02 ET | 18000 | 1.34 |
| 12:07 ET | 400 | 1.33 |
| 12:09 ET | 300 | 1.33 |
| 12:12 ET | 200 | 1.33 |
| 12:14 ET | 100 | 1.33 |
| 12:16 ET | 200 | 1.33 |
| 12:18 ET | 498 | 1.33 |
| 12:20 ET | 100 | 1.3305 |
| 12:21 ET | 2000 | 1.3399 |
| 12:23 ET | 2325 | 1.3394 |
| 12:25 ET | 500 | 1.33 |
| 12:34 ET | 100 | 1.33 |
| 12:43 ET | 100 | 1.34 |
| 12:48 ET | 100 | 1.335 |
| 12:52 ET | 100 | 1.34 |
| 12:54 ET | 400 | 1.33 |
| 12:57 ET | 100 | 1.34 |
| 12:59 ET | 300 | 1.34 |
| 01:33 ET | 582 | 1.33 |
| 01:50 ET | 100 | 1.34 |
| 01:55 ET | 100 | 1.34 |
| 01:57 ET | 100 | 1.3317 |
| 02:02 ET | 100 | 1.34 |
| 02:06 ET | 100 | 1.34 |
| 02:11 ET | 100 | 1.34 |
| 02:24 ET | 900 | 1.35 |
| 02:31 ET | 1093 | 1.34 |
| 02:33 ET | 230 | 1.34 |
| 02:47 ET | 100 | 1.34 |
| 02:56 ET | 100 | 1.34 |
| 03:00 ET | 200 | 1.34 |
| 03:05 ET | 100 | 1.34 |
| 03:09 ET | 100 | 1.34 |
| 03:18 ET | 498 | 1.33 |
| 03:23 ET | 200 | 1.34 |
| 03:27 ET | 100 | 1.34 |
| 03:32 ET | 100 | 1.34 |
| 03:38 ET | 700 | 1.34 |
| 03:39 ET | 500 | 1.34 |
| 03:43 ET | 1001 | 1.33 |
| 03:45 ET | 300 | 1.35 |
| 03:50 ET | 822 | 1.34 |
| 03:52 ET | 200 | 1.34 |
| 03:54 ET | 3578 | 1.3399 |
| 03:57 ET | 1200 | 1.325 |
| 03:59 ET | 1232 | 1.33 |
Apr 18, 2024
Apr 1, 2024
DJ Femasys Is Maintained at Buy by Chardan Capital, from 8:35AM ET on Monday Apr 01, 2024 by Dow Jones
8:35AM ET on Monday Apr 01, 2024 by Dow JonesDJ Femasys Is Maintained at Buy by HC Wainwright & Co., from 6:54AM ET on Monday Apr 01, 2024 by Dow Jones
6:54AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 28, 2024
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow JonesPress Release: Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Femasys Inc | 29.4M | -1.4x | --- |
Nutriband Inc | 30.2M | -5.7x | --- |
bioAffinity Technologies Inc | 28.2M | -2.7x | --- |
MakingORG Inc | 26.7M | -229.4x | --- |
Lucid Diagnostics Inc | 33.0M | -0.5x | --- |
BioRegenx Inc | 38.3M | -19.3x | --- |
Company Information
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
Contact Information
- Headquarters
- 3950 JOHNS CREEK COURT, SUITE 100SUWANEE, GA, United States 30024
- Phone
- 770-500-3910
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Charles Larsen
- President, Chief Executive Officer, Director
- Kathy Lee-Sepsick
- Chief Financial Officer
- Dov Elefant
- Chief Operating Officer, Senior Vice President
- Daniel Currie
- Senior Vice President - Regulatory and Clinical Affairs
- Christine Thomas
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.4M |
|---|---|
Revenue (TTM) | $1.1M |
Shares Outstanding | 22.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.94 |
Book Value | $0.85 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 27.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,353.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
